Overexpression of DLL1 was identified in choriocarcinoma [20] and hepatocellular carcinoma [21], while Delta-like 4 (DLL4) expression was correlated to tumor initiation and progression of glioblastoma [22], poor prognosis in pancreatic cancer [23] and colon cancer [24]. The gene discussed is DLL1; the disease is glioblastoma.